Angel Broking has come out with its earning estimates on the pharmaceutical sector for the quarter ended December 2010. According to the research firm, Ranbaxy Lab December quarter net sales are expected to go up by 0.9% to Rs 2,266 crore, Year-on-Year, (Y-o-Y) basis.

The company's net profit is..

In a bout of restructuring, pharma major Ranbaxy today announced that their New Drug Discovery Research (NDDR) has been transferred to Daiichi Sankyo India Pharma Private Limited under the rationale of strengthening the global R&D of Daiichi Sankyo Group.

The new company formed will be Daiichi S..

MUMBAI: Portfolio investors are positive on the India structural story. Foreign fund managers from GIC, Boston-based Mass Financial, Janus, T Rowe Price, Boston-based Wellington Management, Singapore-based Aberdeen Asset Management and Fidelity, which were recently in India, have indicated that they..

Share of pharma major Ranbaxy ended marginally down on Friday despite opening the day on a buoyant note. The buzz is that some traders have been
accumulating the stock over the past few weeks. Initially, it was thought that the buyers were betting on strong quarterly earnings.

The numbers disapp..

MUMBAI: Indian equity benchmarks surged in the last half hour of trade on Tuesday to end above psychological resistance levels, taking cues from positive European markets. All the sectoral indices ended in the green, with auto, IT and metals in the lead.

Market opened on a positive note but turn..